1. |
Reynolds MM, Veverka KK, Gertz MA, et al. Ocular manifestations of familial transthyretinamyloidosis[J]. Am J Ophthalmol, 2017, 183: 156-162. DOI: 10.1016/j.ajo.2017.09.001.
|
2. |
Liu T, Zhang B, Jin X, et al. Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation[J]. Eye (Lond), 2014, 28(1): 26-33. DOI: 10.1038/eye.2013.217.
|
3. |
Adams D, Ando Y, Beirão JM, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy[J]. J Neurol, 2021, 268(6): 2109-2122. DOI: 10.1007/s00415-019-09688-0.
|
4. |
Yin J, Xia X, Shi Y, et al. Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review[J]. Amyloid, 2014, 21(2): 140-142. DOI: 10.3109/13506129.2014.892871.
|
5. |
Ran LX, Zheng ZY, Xie B, et al. A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only[J]. Exp Eye Res, 2018, 169: 13-19. DOI: 10.1016/j.exer.2018.01.017.
|
6. |
Zhang AM, Wang H, Sun P, et al. Mutation p. G83R in the transthyretin gene is associated with hereditary vitreous amyloidosis in Han Chinese families[J]. Mol Vis, 2013, 19: 1631-1638.
|
7. |
Kakihara S, Hirano T, Imai A, et al. Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis[J/OL]. Sci Rep, 2020, 10(1): 5574[2020-03-27]. https://pubmed.ncbi.nlm.nih.gov/32221479/. DOI: 10.1038/s41598-020-62559-x.
|
8. |
Koga T, Ando E, Hirata A, et al. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy[J]. Am J Ophthalmol, 2003, 135(2): 188-193. DOI: 10.1016/s0002-9394(02)01838-x.
|
9. |
谢兵, 蔡善君, 郑志涌. 家族性玻璃体淀粉样变性甲状腺激素结合蛋白Gly83Arg突变一家系[J]. 中华眼底病杂志, 2016, 32(3): 312-314. DOI: 10.3760/cma.j.issn.1005-1015.2016.03.021.Xie B, Cai SJ, Zheng ZY. Familial vitreous amyloidosis thyroid hormone binding protein Gly83Arg mutant family[J]. Chin J Ocul Fundus Dis, 2016, 32(3): 312-314. DOI: 10.3760/cma.j.issn.1005-1015.2016.03.021.
|
10. |
Dammacco R, Merlini G, Lisch W, et al. Amyloidosis and ocular involvement: an overview[J]. Semin Ophthalmol, 2020, 35(1): 7-26. DOI: 10.1080/08820538.2019.1687738.
|
11. |
Venkatesh P, Selvan H, Singh SB, et al. Vitreous amyloidosis: ocular, systemic, and genetic insights[J]. Ophthalmology, 2017, 124(7): 1014-1022. DOI: 10.1016/j.ophtha.2017.03.011.
|
12. |
谢渊, 赵艳, 周建奖, 等. 一个遗传性玻璃体淀粉样变性家系TTR基因的突变检测[J]. 中华医学遗传学杂志, 2012, 29(1): 13-15. DOI: 10.3760/cma.j.issn.1003-9406.2012.01.004.Xie Y, Zhao Y, Zhou JJ, et al. Identification of a TTR gene mutation in a family with hereditary vitreous amyloidosis[J]. Chin J Med Genet, 2012, 29(1): 13-15. DOI: 10.3760/cma.j.issn.1003-9406.2012.01.004.
|
13. |
Beirão JM, Malheiro J, Lemos C, et al. Impact of liver transplantation on the natural history of oculopathy in portuguese patients with transthyretin (V30M) amyloidosis[J]. Amyloid, 2015, 22(1): 31-35. DOI: 10.3109/13506129.2014.989318.
|
14. |
Marques JH, Coelho J, Malheiro J, et al. Subclinical retinal angiopathy associated with hereditary transthyretin amyloidosis-assessed with optical coherence tomography angiography[J]. Amyloid, 2020, 28(1): 66-71. DOI: 10.1080/13506129.2020.1827381.
|
15. |
O'Hearn TM, Fawzi A, He S, et al. Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF[J]. Br J Ophthalmol, 2007, 91(12): 1607-1609. DOI: 10.1136/bjo.2007.119495.
|